Search
+
    SEARCHED FOR:

    INDIA US CORONAVIRUS

    Pill for China plus one

    Indian pharma CEOs met senior officials in FDA and other key agencies to start a conversation. Even if a little late, given the looming presidential election, the proposal deserves attention. The basic idea is to capitalise on India's expertise and infra for manufacturing through financial incentives, tech sharing, collaborative research and tech transfers to expand production in both countries. Pursue onshoring in America and friendshoring in India to reduce dependence on China. And aggregate US, Indian and European demand for certain drugs, as IPA secretary general Sudarshan Jain told me.

    Domestic airfares on northward trajectory; still among lowest globally: Experts

    Domestic airfares in India have surged up to 40% in key routes due to higher traffic and capacity constraints in the last six quarters. India is one of the world's fastest-growing civil aviation markets, with an average of 4.5 lakh passengers daily. However, capacity constraints are a key challenge as many aircraft are grounded due to supply chain issues. Aviation consultancy firm CAPA India reported that average fares on the top 20 domestic routes had not moved significantly in nominal terms for the last two decades, until the last six quarters.

    How GoI’s post-poll domestic authority will shape New Delhi’s geopolitics

    With India's key strategic partner Russia more firmly entrenched and aligned with China in 2024, the domestic political authority the next government in New Delhi brings to the table - and the way it deploys this capital - will hold the key to how it can position itself at the start of a turbulent phase between a relatively stronger, expanding Russia-China arc of power and a politically strife-ridden democratic coalition of powers.

    Good shot, bad shot: What you need to know about Covishield issue

    Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and demands for compensation have emerged as families of alleged victims seek justice. Experts stress the importance of understanding risks versus benefits in vaccine administration.

    We're alive because Modi ensured COVID vaccine for us: Fadnavis

    Indian Prime Minister Narendra Modi has been credited with facilitating the manufacture and administration of the COVID vaccine during the pandemic, according to Maharashtra Deputy Chief Minister Devendra Fadnavis. Nearly 100 countries credit Modi for providing vaccine doses and protecting their citizens from the virus, referring to the Centre's 'Vaccine Maitri' initiative. Fadnavis said that the world did not know that Modi was at the helm of India's leadership who knew how to protect his people.

    The U.S. seems to be dodging a recession. What could go wrong?

    Inflation falling, unemployment low, and the Federal Reserve could cut interest rates. Wells Fargo economists predict a soft landing, but still see elevated recession risk due to signs of weakness in the labor market. The effects of higher interest rates may be slower this time as companies refinance debt and buffers like savings and credit card borrowing dwindle. The return of inflation could put policymakers in a tight spot, unable to cut rates and potentially considering rate hikes. Unforeseen events like disruptions in shipping lanes or new threats could upset the balance and create job loss.

    • COVID-19: India records biggest single-day jump in cases in 7 months

      On Saturday, according to the latest update from the Union Health Ministry, India witnessed a surge of 752 new coronavirus infections in a single day, marking the highest since May 21, 2023. The total number of active cases has now risen to 3,420. The death toll stands at 5,33,332, with four new fatalities reported in the past 24 hours. Among these, two deaths occurred in Kerala, while Rajasthan and Karnataka each recorded one death.

      At 614, single-day Covid case count is at a 7-month high

      The Indian SARS-CoV-2 Genomics Consortium (Insacog), the network of laboratories set up to monitor genomic variations of the coronavirus, has so far found 21 cases of infection with the JN.1 subvariant, which the World Health Organization (WHO) has declared as a "variant of interest".

      Covid JN.1 virus arrives in India: What are the symptoms, precautions and should you worry?

      A new sub-variant of the coronavirus, named JN.1, has been detected in a woman from Kerala, marking the first case in India. JN.1 is closely related to the BA.2.86 variant found in the US and China. It has an additional spike protein mutation, potentially making it more transmissible and capable of evading immunity.

      Wait time for getting interview appointment for B1 and B2 US visas 37 days in Delhi

      According to the data updated November 1 on the website, the current waiting period for getting an interview appointment for an American visa in the B1 and the B2 categories stands at 37 days in Delhi, 322 days in Mumbai, 126 days in Kolkata, 341 days in Chennai and 511 days in Hyderabad.

      Covid-19 variant 2023: US, UK, 2 other countries detect highly mutated Coronavirus variant. Details here

      Covid-19 virus variant has reportedly been detected in the US, the UK, Denmark, and Israel. The coronavirus variant is dubbed as BA.2.86 and informally referred to as Pirola among variant trackers on social platforms.

      India-born college student is first Republican to enter US Senate race in Wisconsin

      Rejani Raveendran, a 37-year-old Indian-American, has announced her candidacy for the US Senate for Wisconsin, becoming the first Republican to stand against Democratic Senator Tammy Baldwin. A mother of three, Raveendran, who has never run for office in the state before, said she stood because she was concerned the political landscape had become dominated by polished politicians and that there was a need for a change.

      India daily covid cases fall slightly but still more than 10,000

      Active cases went up by 3822 to 57542 while 6248 recovered in past 24 hours. Delhi had 4631 active cases, Kerala 19,481 and Maharashtra 6047.

      US-China split could hinder foreign investment and lower global GDP, IMF warns

      According to the IMF, such a split between US and China since 2016 has potential to negative impact bilateral cross-border investment portfolios .

      Amid Covid rise, no clustering and unusual pattern a relief for India

      Active cases have continued to rise in India for 33 days to the highest since November last year. India saw a single-day rise of more than 1,000 fresh Covid-19 cases after 129 days, while active cases rose to 5,915, according to Union health ministry data on Sunday.

      How serious is the recent Covid spike in India?

      India has reported 524 new Covid-19 cases in 24 hours after 113 days, shows Union health ministry data updated on Sunday. The spike is more prominent in Kerala , Maharashtra, Gujarat and Karnataka. The country had reported a single-day spike of over 500 in November last year. The active caseload in the country has risen to 3,618.

      Five cases of XBB.1.5 coronavirus variant found in India, says INSACOG

      ​Responsible for a rise in cases in America, the variant was found in Gujarat and Karnataka and Rajasthan. The XBB.1.5 strain is a relative of the Omicron XBB variant, which is a recombinant of the Omicron BA.2.10.1 and BA.2.75 subvariants. Combined, XBB and XBB.1.5 make up 44% of cases in the US.

      India confirms first case of Omicron variant XBB.1.5. Everything you need to know

      XBB.1.5 is a sub-variant that international scientists have flagged for being responsible for a surge in Covid cases and hospitalisations in New York. XBB itself is a recombinant of two different BA.2 sub-variants of Omicron. But its descendant, XBB.1.5, is believed to have a tighter bind to the ACE2 receptor, which would explain its higher level of transmissibility, a TOI report said, quoting US scientist Eric Topol.

      India emerging as attractive investment destination, says SBI report

      India seems to be a clear beneficiary in terms of an attractive investment destination as investment opportunities drag for China, stated a research report by State Bank of India (SBI). According to the report, India appears to be emerging as the best option with a positive growth and inflation outlook in the current fiscal.

      Load More
    The Economic Times
    BACK TO TOP
    Advertisement